This document is an attestation letter from Neuspera Medical Inc. to the Federal Communications Commissions (FCC). The letter addresses the requirements for equipment authorization as outlined in CFR 47 §2.911(d)(5)(i) Filing. The purpose of the letter is to certify that the equipment for which authorization is being sought is not considered "covered" equipment, meaning it is not prohibited from receiving an equipment authorization under section 2.903 of the FCC rules.
The letter includes the FCC ID (2BMNE-WT-002) for the equipment in question. It is signed by Dr. Alexander Yeh, CTO, VP R&D of Neuspera Medical Inc., and includes his contact information. The document also provides the company's address and confirms their compliance with the specified FCC regulations.
This attestation is a necessary step in the process of obtaining FCC authorization for Neuspera Medical Inc.'s equipment, ensuring that it meets the required standards and is eligible for use in the United States.
Array
(
[0] => Array
(
[url_sha] => 56bec3c8f9e385f292cd2e3b495affac9908cf360d3473b85762a9a15d62e49d
[source] => fccid
[url] => https://apps.fcc.gov/eas/GetApplicationAttachment.html?id=8308086
[href_text] => 2.911 (d)(5)(i) Attestation Statement
[href_description] => Neuspera Medical Inc. WT-002 Neurostimulator Powering Device 2BMNE-WT-002 2BMNEWT002 wt 002
[http_status] => 200
[http_lastmod] => 0000-00-00 00:00:00
[http_contenttype] =>
[http_filename] => GetApplicationAttachment.html?id=8308086
[http_size] => 309968
[file_sha256] => 4a3453fa0fd4bd0c974394ae38f8f5093829523ad6c9afca0b50da4d3842d0ae
[domain] => document.fccid
)
)
Array
(
[file_sha256] => 4a3453fa0fd4bd0c974394ae38f8f5093829523ad6c9afca0b50da4d3842d0ae
[cleanFccId] => 2BMNEWT002
[title] => Neuspera Medical Inc. Attestation Letter for FCC Authorization
[description] => Attestation letter from Neuspera Medical Inc. certifying compliance with FCC regulations for equipment authorization filing.
[brand_name] => Neuspera
[keywords] => ["2BMNE-WT-002", "Neuspera Medical Inc.", "Attestation Statement", "FCC Filing", "WT-002"]
[intro] =>
This document is an attestation letter from Neuspera Medical Inc. to the Federal Communications Commissions (FCC). The letter addresses the requirements for equipment authorization as outlined in CFR 47 §2.911(d)(5)(i) Filing. The purpose of the letter is to certify that the equipment for which authorization is being sought is not considered "covered" equipment, meaning it is not prohibited from receiving an equipment authorization under section 2.903 of the FCC rules.
The letter includes the FCC ID (2BMNE-WT-002) for the equipment in question. It is signed by Dr. Alexander Yeh, CTO, VP R&D of Neuspera Medical Inc., and includes his contact information. The document also provides the company's address and confirms their compliance with the specified FCC regulations.
This attestation is a necessary step in the process of obtaining FCC authorization for Neuspera Medical Inc.'s equipment, ensuring that it meets the required standards and is eligible for use in the United States.
)
Array
(
[0] => Array
(
[id] => 8308086
[file_sha256] =>
[applicationId] => r4BN3DPg6fQa6D9VGAMKkg==
[description] => 2.911 (d)(5)(i) Attestation Statement
[shortTermConfidential] => No
[permanentConfidential] => No
[supercede] => No
[exhibitType] => Attestation Statements
[fileType] => Adobe Acrobat PDF
[displayType] => pdf
[fileSize] => 309968
[submissionDate] => 2025-05-20 00:00:00
[dateAvailable] => 2025-05-20 00:00:00
[creationDate] =>
[producer] =>
[modDate] =>
[title] =>
[creator] =>
[author] =>
[pages] =>
[realSize] =>
[html] => 0
[png] => 0
[txt] => 0
[version] => 1
[source] => 0
[fccId] => 2BMNE-WT-002
[cleanFccId] => 2BMNEWT002
[exif] => 0
)
)